STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 75 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,621,000 | -68.7% | 794,675 | -54.5% | 0.02% | -65.4% |
Q2 2021 | $5,182,000 | +7.6% | 1,744,669 | 0.0% | 0.05% | +15.6% |
Q1 2021 | $4,815,000 | -43.2% | 1,744,669 | -50.0% | 0.04% | -39.2% |
Q4 2020 | $8,479,000 | +15.7% | 3,489,369 | 0.0% | 0.07% | -19.6% |
Q3 2020 | $7,328,000 | – | 3,489,369 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 8,089,442 | $19,657,000 | 12.25% |
Stonepine Capital Management, LLC | 1,350,000 | $3,281,000 | 2.51% |
AIGH Capital Management LLC | 1,764,173 | $4,287,000 | 1.74% |
Worth Venture Partners, LLC | 449,046 | $1,091,000 | 0.86% |
NEA Management Company, LLC | 4,141,308 | $10,063,000 | 0.27% |
Ikarian Capital, LLC | 2,440,028 | $5,929,000 | 0.26% |
683 Capital Management, LLC | 1,595,082 | $3,876,000 | 0.18% |
Orbimed Advisors | 3,489,369 | $8,479,000 | 0.07% |
HighVista Strategies LLC | 28,432 | $69,000 | 0.04% |
ALGERT GLOBAL LLC | 52,597 | $128,000 | 0.04% |